Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;8(1):102–108. doi: 10.1111/j.1582-4934.2004.tb00264.x

Renal cortex remodeling in nitric oxide deficient rats treated with enalapril

Noemi Barbuto 1, Jorge Reis Almeida 1, Leila Maria Meirelles Pereira 1, Carlos Alberto Mandarim‐de‐Lacerda 1,✉
PMCID: PMC6740241  PMID: 15090265

Abstract

The kidney NO synthase is one of the most important renal controlling systems. This paper aims the quantification of renal cortical components involved in blood pressure regulation under NOs blockade. Spontaneous hypertensive rats (SHRs) are submitted to chronic blockade of NOs by L‐nitro‐arginine‐methyl‐ester (L‐NAME) and an ACE inhibitor (enalapril) in comparison with the normotensive Wistar rats. Twenty SHRs and 5 Wistar rats were divided in 5 groups and observed for 21 days for blood pressure (BP) and serum creatinine: control Wistar (5) (C‐W), control SHR (5) (C‐SHR), L‐SHR (5) ‐ received L‐NAME 30 mg/kg/day, L+E‐SHR (5) ‐ received L‐NAME and Enalapril maleate 15 mg/kg/day, E‐SHR (5) ‐ received Enalapril maleate. A quantitative morphometric study (glomerular density, QA[g1], interstitium volume density, Vv[i], tubular surface and length densities, Sv[t] and Lv[t]) were performed at the end. The BP reached 226±15 mmHg in L‐SHR group. The BP difference between the L‐SHR and the C‐SHR groups was significant from the first week while the E‐SHR group became significant from the second week. At the end of the experiment the BP of the E‐SHR group was similar to the BP in the C‐W group. The QA[g1] was similar among C‐SHR, L‐SHR and L+E‐SHR groups and no difference was found between E‐SHR and C‐W groups. In the L‐SHRs serum creatinine was greatly increased, and microscopy showed thickening of arteriolar tunica media with an increase of the wall‐to‐lumen ratio, perivascular fibrosis, inflammatory infiltrated, tubular atrophy and interstitial fibrosis with focal segmental glomerulosclerosis. The use of enalapril was not completely efficient in reducing BP and morphological injury when the hypertension of SHRs was increased with the NOs blockade suggesting that NO deficiency‐induced hypertension is not entirely mediated by the RAAS.

Keywords: Hypertension, kidney, nitric oxide, rennin‐angiotensin system, ACE inhibitor, stereology

References

  • 1. Moncada S., Higgs E.A., Endogenous nitric oxide: physiology, pathology and clinical relevance, Eur. J. Clin. Invest., 21: 361–374, 1991. [DOI] [PubMed] [Google Scholar]
  • 2. Rodeberg D.A., Chaet M.S., Bass R.C., Arkovitz M.S., Garcia V.F., Nitric oxide: an overview, Am. J. Surg., 170: 292–303, 1995. [DOI] [PubMed] [Google Scholar]
  • 3. Porsti I., Paakkari I., Nitric oxide‐based possibilities for pharmacotherapy, Ann. Med., 27: 407–420, 1995. [DOI] [PubMed] [Google Scholar]
  • 4. Majid D.S., Navar L.G., Nitric oxide in the control of renal hemodynamics and excretory function, Am. J. Hypertens., 14: 74S–82S, 2001. [DOI] [PubMed] [Google Scholar]
  • 5. Ribeiro M.O., Antunes E., De Nucci G., Lovisolo S.M., Zatz R., Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension, Hypertension, 20: 298–303, 1992. [DOI] [PubMed] [Google Scholar]
  • 6. Pereira L.M., Mandarim‐de‐Lacerda C.A., Quantitative examination of the cardiac myocytes in hypertensive rats under chronic inhibition of nitric oxide synthesis, J. Biomed. Sci., 5: 363–369, 1998. [DOI] [PubMed] [Google Scholar]
  • 7. Kone B.C., Baylis C., Biosynthesis and homeostatic roles of nitric oxide in the normal kidney, Am. J. Physiol., 272: F561–578, 1997. [DOI] [PubMed] [Google Scholar]
  • 8. Madrid M.I., Garcia‐Salom M., Tornel J., De Gasparo M., Fenoy F.J., Interactions between nitric oxide and angiotensin II on renal cortical and papillary blood flow, Hypertension, 30: 1175–1182, 1997. [DOI] [PubMed] [Google Scholar]
  • 9. Ono H., Ono Y., Frohlich E.D., Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics, Hypertension, 26: 249–255, 1995. [DOI] [PubMed] [Google Scholar]
  • 10. Pereira L.M., Mandarim‐de‐Lacerda C.A., Glomerular profile numerical density per area and mean glomerular volume in rats submitted to nitric oxide synthase blockade, Histol. Histopathol., 16: 15–20, 2001. [DOI] [PubMed] [Google Scholar]
  • 11. Kett M.M., Bergstrom G., Alcorn D., Bertram J.F., Anderson W.P., Renal vascular resistance properties and glomerular protection in early established SHR hypertension. J. Hypertens., 19: 1505–1512, 2001. [DOI] [PubMed] [Google Scholar]
  • 12. Nyengaard J.R., Stereologic methods and their application in kidney research, J. Am. Soc. Nephrol., 10: 1100–1123, 1999. [DOI] [PubMed] [Google Scholar]
  • 13. Bertram J.F., Counting in the kidney, Kidney Int., 59: 792–796, 2001. [DOI] [PubMed] [Google Scholar]
  • 14. Cruz‐Orive L.M., Weibel E.R., Recent stereological methods for cell biology: a brief survey, Am. J. Physiol., 258: L148–156, 1990. [DOI] [PubMed] [Google Scholar]
  • 15. Scherle W., A simple method for volumetry of organs in quantitative stereology, Mikroskopie, 26: 57–60, 1970. [PubMed] [Google Scholar]
  • 16. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect, J. Microsc., 111: 219–227, 1977. [Google Scholar]
  • 17. Zar J.H., Biostatistical analysis. 4th ed. Upper Saddle River : Prentice‐Hall; 1999. [Google Scholar]
  • 18. Baylis C., Mitruka B., Deng A., Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage, J. Clin. Invest., 90: 278–281, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Bouriquet N., Casellas D., Chronic L‐NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels, Am. J. Physiol., 269: F190–197, 1995. [DOI] [PubMed] [Google Scholar]
  • 20. Verhagen A.M., Koomans H.A., Joles J.A., Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition, Eur. J. Pharmacol., 411: 175–180, 2001. [DOI] [PubMed] [Google Scholar]
  • 21. Francischetti A., Ono H., Frohlich E.D., Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L‐NAME, Hypertension, 31: 795–801, 1998. [DOI] [PubMed] [Google Scholar]
  • 22. Millatt L.J., Abdel‐Rahman E.M., Siragy H.M., Angiotensin II and nitric oxide: a question of balance, Regul. Pept., 81: 1–10, 1999. [DOI] [PubMed] [Google Scholar]
  • 23. Sanchez‐Mendoza A., Hong E., Escalante B., The role of nitric oxide in angiotensin II‐induced renal vasoconstriction in renovascular hypertension, J. Hypertens., 16: 697–703, 1998. [DOI] [PubMed] [Google Scholar]
  • 24. McLay J.S., Chatterjee P.K., Mistry S.K., Weerakody R.P., Jardine A.G., McKay N.G., Hawksworth G.M., Atrial natriuretic factor and angiotensin II stimulate nitric oxide release from human proximal tubular cells, Clin. Sci. (Lond.), 89: 527–531, 1995. [DOI] [PubMed] [Google Scholar]
  • 25. Leclercq B., Jaimes E.A., Raij L., Nitric oxide synthase and hypertension, Curr. Opin. Nephrol. Hypertens., 11: 185–189, 2002. [DOI] [PubMed] [Google Scholar]
  • 26. Brenner B.M., Garcia D.L., Anderson S., Glomeruli and blood pressure. Less of one, more the other Am. J. Hypertens., 1: 335–347, 1988. [DOI] [PubMed] [Google Scholar]
  • 27. Caetano E.R., Zatz R., Saldanha L.B., Praxedes J.N. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension, 38: 171–176, 2001. [DOI] [PubMed] [Google Scholar]
  • 28. Zatz R., Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension, 32: 958–964, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ono H., Ono Y., Frohlich E.D. ACE inhibition prevents and reverses L‐NAME‐exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension, 27: 176–183, 1996. [DOI] [PubMed] [Google Scholar]
  • 30. Skov K., Nyengaard J.R., Korsgaard N., Mulvany M.J., Number and size of renal glomeruli in spontaneously hypertensive rats, J. Hypertens., 12: 1373–1376, 1994. [PubMed] [Google Scholar]
  • 31. Tucker M.J., Diseases of the Wistar rat. Bristol : Taylor & Francis; 1997. [Google Scholar]
  • 32. Mandarim‐de‐Lacerda C.A., Pereira L.M., Renal cortical remodelling by NO‐synthesis blockers in rats is prevented by angiotensin‐converting enzyme inhibitor and calcium channel blocker, J. Cell. Mol. Med., 5: 276–283, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. De Andrade Zorzi R.L., Meirelles Pereira L.M., Mandarimde‐Lacerda C.A., Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade, J. Cell. Mol. Med., 6: 599–608, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES